Your Flagship Cell Therapy Forum for End-to-End Success
Tap into exclusive, industry-defining insights on CAR and TCR construct design, shielding and gating to tackle the solid tumor microenvironment, patient-centric clinical trial design, automated manufacturing integration, and unlocking commercial impact to secure the clinical and commercial success of your pipeline.
Expect unmissable conversations with the industry’s top KOLs, C-suite and senior executives and leading solution providers. With perspectives from every angle, sharpen strategy, and explore collaborative opportunities to accelerate the delivery of life-saving therapies to patients in need.
New Unmissable Event Highlights
Investors Panel Discussion
Connect directly with investors in an open discussion forum to understand their interests, expectations and investment drivers, and ask your burning questions to build a funding package that wins.
Speakers include:
- Ilya Yasny, Partner, LanceBio Ventures/Bioptic
- Patrick Rivers, Portfolio Manager, AMoon fund
- Randy Berholtz, Senior Advisor, Mersa Verde Venture Partners
- Koji Yasuda, Principal, Fast Track Initiative
Unpublished Clinical Data Presentations
Be the first to access the latest industry-progressing Phase I and II clinical data spanning solid tumors, hematological malignancies and autoimmune diseases to uncover what’s delivering real clinical validation.
Speakers include:
- Natalie Shiff, Senior Medical Director, Fate Therapeutics
- Helen Sabzevari, President & Chief Executive Officer, Precigen
- Pei Wang, Senior Vice President, Clinical Development & CMC, Eureka Therapeutics
- Bruce Levine, Barabara & Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
- Ed Zhang, Co-Founder & Chief Executive Officer, Overland Pharmaceuticals
3 New
Bootcamps
Get ahead with a full day of additional insights at our re-imagined pre-conference day, featuring 3 new tracks: In Vivo, Automated Manufacturing, and Pharma & Investment Partnerships.
Speakers include:
- Xiuyan Wang, Director, Biotherapeutics Core Facility, Memorial Sloan Kettering Cancer Center
- Nikhil Mutyal, Global Head, Search & Evaluation, Respiratory & Immunology, AstraZeneca
- Peggy Sotiropoulou, Chief Scientific Officer, T-Knife Therapeutics
Cutting-Edge Scientific Content Catering to all Stages of Development:
Discovery & Translation
Advance Novel Modalities & Biomarkers with AI, In Vivo Innovation & Translational Relevance
Speakers:
Clinical
Accelerate Clinical Impact with Smarter Trial Design, Early Apheresis & Patient-Centric Strategies
Speakers:
Early-Stage Manufacturing
Build Phase 1 Processes with Speed, Flexibility & a Clear Path to Commercialization
Speakers:
Late-Stage Manufacturing
Scale Up, Reduce Costs & Ensure Quality in Phase 2 & Beyond
Speakers:
Explore the Full Event Guide
- Discover 75+ industry-leading speakers from across biotech, commercialized pharma, venture capital and academic KOLs
- Get a preview of all featured unpublished phase I and II clinical data presentation descriptions and the industry's latest breakthroughs
- Explore who you’ll be connecting with to map out your conversations across 14 hours of focused networking
Attending Companies Include
Explore the Agenda
Get a front row seat to the latest cell therapy breakthroughs across emerging autoimmune and disease, solid tumors and novel modalities through data-driven technical presentations, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of cell therapy deals.
Join Biopharma Experts
Be part of the hottest conversations in this tailor-made forum for senior executives across all stages of CAR and TCR drug development and make critical connection during our dedicated networking sessions and CAR-TCR Connect drinks reception.